Identifying a malignant B-cell lymphoma clone in peripheral blood using immunoglobulin high-throughput sequencing and lineage tree analysis
Corresponding Author
Meirav Kedmi
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Correspondence
Meirav Kedmi, Head of Lymphoma Service, Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan 5262100, Israel.
Email: [email protected]
Search for more papers by this authorHadas Neuman
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Search for more papers by this authorGuy Bitansky
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Search for more papers by this authorMeital Nagar
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorGaelle Scheinert-Shenhav
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorIris Barshack
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorGinette Schiby
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorHilla Tabibian-Keissar
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorAbraham Avigdor
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Search for more papers by this authorRamit Mehr
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Search for more papers by this authorCorresponding Author
Meirav Kedmi
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Correspondence
Meirav Kedmi, Head of Lymphoma Service, Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan 5262100, Israel.
Email: [email protected]
Search for more papers by this authorHadas Neuman
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Search for more papers by this authorGuy Bitansky
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Search for more papers by this authorMeital Nagar
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorGaelle Scheinert-Shenhav
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorIris Barshack
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorGinette Schiby
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorHilla Tabibian-Keissar
Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, Israel
Search for more papers by this authorAbraham Avigdor
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
Search for more papers by this authorRamit Mehr
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel
Search for more papers by this authorFunding information: Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States-Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar-Ilan University
Open Research
DATA AVAILABILITY STATEMENT
Mehr lab scripts mentioned in the Methods section are available upon request. The sequence data will be made available upon paper acceptance.
REFERENCES
- 1Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018; 50: 74-87.
- 2Kurtz DM, Green MR, Bratman SV, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015; 125: 3679-3687.
- 3Rossi D, Diop F, Spaccarotella E, et al. Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 2017; 129: 1947-1957.
- 4Kotrova M, Muzikova K, Mejstrikova E, et al. The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL. Blood. 2015; 126: 1045-1047.
- 5Neuman H, Arrouasse J, Kedmi M, Cerutti A, Magri G, Mehr R. IgTreeZ, a toolkit for immunoglobulin gene lineage tree-based analysis, reveals CDR3s are crucial for selection analysis. Front Immunol. 2022; 13: 822834.
- 6Carlotti E, Wrench D, Matthews J, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood. 2009; 113: 3553-3557.
- 7Kedmi M, Ribakovsy E, Benjamini O, et al. Ibrutinib, Bendamustine, rituximab combination for relapsed and refractory aggressive B cell lymphoma — interim analysis of phase II clinical trial. Blood. 2018; 132: 4186.
- 8Tabibian-Keissar H, Schibby G, Michaeli M, et al. PCR amplification and high throughput sequencing of immunoglobulin heavy chain genes from formalin-fixed paraffin-embedded human biopsies. Exp Mol Pathol. 2013; 94: 182-187.
- 9Vander Heiden JA, Yaari G, Uduman M, et al. pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics. 2014; 30: 1930-1932.
- 10Gupta NT, Vander Heiden JA, Uduman M, Gadala-Maria D, Yaari G, Kleinstein SH. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics. 2015; 31: 3356-3358.
- 11Barak M, Zuckerman NS, Edelman H, Unger R, Mehr R. IgTree: creating immunoglobulin variable region gene lineage trees. J Immunol Methods. 2008; 338: 67-74.
- 12Laydon DJ, Bangham CR, Asquith B. Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach. Philos Trans R Soc Lond B Biol Sci. 2015; 370: 20140291.
- 13Greiff V, Bhat P, Cook SC, Menzel U, Kang W, Reddy ST. A bioinformatic framework for immune repertoire diversity profiling enables detection of immunological status. Genome Med. 2015; 7: 49.
- 14Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32: 3059-3068.
Citing Literature
